Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedThe history now shows a new revision entry (v3.5.4) replacing the previous one (v3.5.3), indicating an update to the record metadata.SummaryDifference0.0%

- Check12 days agoChange DetectedThe history now includes new sections for Contacts/Locations and Study Status (with dates 2026-04-22 and 2026-05-07), enhancing visibility into site contacts and the trial's current status. An older entry dated 2025-07-08 was removed.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial record history.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page history.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the study record history.SummaryDifference0.0%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.